SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-12-469754
Filing Date
2012-11-14
Accepted
2012-11-14 12:37:03
Documents
11
Period of Report
2012-09-30
Filing Date Changed
2012-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398699d10q.htm 10-Q 597590
2 EX-31.1 d398699dex311.htm EX-31.1 8271
3 EX-31.2 d398699dex312.htm EX-31.2 8258
4 EX-32.1 d398699dex321.htm EX-32.1 3862
5 EX-32.2 d398699dex322.htm EX-32.2 2620
  Complete submission text file 0001193125-12-469754.txt   3166238

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20120930.xml EX-101.INS 369094
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20120930.xsd EX-101.SCH 34609
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20120930_cal.xml EX-101.CAL 41057
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20120930_def.xml EX-101.DEF 88945
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20120930_lab.xml EX-101.LAB 257573
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20120930_pre.xml EX-101.PRE 176127
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 121202531
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1